NDC 71335-0147

verapamil hydrochloride

Verapamil Hydrochloride

verapamil hydrochloride is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Verapamil Hydrochloride.

Product ID71335-0147_c7647f8c-87a2-4ec7-bedc-a3ca68f8f132
NDC71335-0147
Product TypeHuman Prescription Drug
Proprietary Nameverapamil hydrochloride
Generic NameVerapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2009-09-17
Marketing CategoryANDA / ANDA
Application NumberANDA078906
Labeler NameBryant Ranch Prepack
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength240 mg/1
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71335-0147-1

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0147-1)
Marketing Start Date2011-09-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0147-2 [71335014702]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-09-12

NDC 71335-0147-1 [71335014701]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-09-12

NDC 71335-0147-3 [71335014703]

verapamil hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078906
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-09-12

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE240 mg/1

OpenFDA Data

SPL SET ID:ed634776-1bd3-4b3a-8e62-e43d3f8904cd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897640
  • 897649
  • 897659

    • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]